Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models
Background: Amifostine is a potent scavenger of reactive oxygen species that is used for the salivary gland protection during therapy with radioactive iodine for thyroid cancer. There are no data on the potential effect of amifostine on thyroid cancer cells. Methods: We investigated the effects of...
Main Authors: | Joanna Klubo-Gwiezdzinska, John Costello Jr, Kirk Jensen, Aneeta Patel, Rok Tkavc, Douglas Van Nostrand, Kenneth D Burman, Leonard Wartofsky, Vasyl Vasko |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2017-09-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/6/7/469.full |
Similar Items
-
The Protective Effect of Amifostine on Radiation-Induced Proctitis: Systemic Versus Topical Application
by: Cem Uzal, et al.
Published: (2012-03-01) -
The therapeutic potential of amifostine on cyclophosphamide-induced testicular dysfunction in rats: An experimental study
by: Coskun Kaya, et al.
Published: (2019-04-01) -
Assessment of the Cytoprotective Efficacy of Amifostine with Quantitative Salivary Gland Scintigraphy
by: Bilgehan Karadayı, et al.
Published: (2005-01-01) -
Effect of amifostine on sperm DNA fragmentation and testes after radioiodine treatment
by: Sen Cigdem Cebi, et al.
Published: (2017-12-01) -
Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer
by: Athanasios Bikas, et al.
Published: (2020-09-01)